Trailblazing Stem Cell Research: New Hope for Schizophrenia Patients
A recent study led by Dr. Sergiu Pasca at Stanford University suggests that human induced pluripotent stem cells (iPSCs) could be used to identify potential new medications for schizophrenia. The research team developed a novel technique to produce astrocytes, star-shaped cells that support neurons, from iPSCs derived from patients with schizophrenia. Astrocytes play a critical […]
StemBioSys Announces Launch of NeuroMatrix™, a Technological Leap Forward in Laboratory Production of Functionally Mature Human Neural Cell Types
SAN ANTONIO, Feb. 13, 2023 /PRNewswire/ — StemBioSys, Inc. (StemBioSys) announced today the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that enables the culture of human induced pluripotent stem cell (hiPSC) derived and primary neural cell types. StemBioSys designed NeuroMatrix™ to expand the use of iPSC-derived neurons in drug discovery and toxicity testing. “NeuroMatrix™ represents a breakthrough in hiPSC-derived neuronal development […]